Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC).

Faehling M, Achenbach J, Staib P, Steffen U, Tessen HW, Gaillard VE, Brugger W.

J Cancer Res Clin Oncol. 2018 Jul;144(7):1375-1383. doi: 10.1007/s00432-018-2649-x. Epub 2018 Apr 23.

PMID:
29687154
2.

Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.

Gluz O, Nitz U, Liedtke C, Christgen M, Grischke EM, Forstbauer H, Braun M, Warm M, Hackmann J, Uleer C, Aktas B, Schumacher C, Bangemann N, Lindner C, Kuemmel S, Clemens M, Potenberg J, Staib P, Kohls A, von Schumann R, Kates R, Kates R, Schumacher J, Wuerstlein R, Kreipe HH, Harbeck N.

J Natl Cancer Inst. 2018 Jun 1;110(6):628-637. doi: 10.1093/jnci/djx258.

PMID:
29228315
3.

Observer-blind randomized controlled study of a cosmetic blend of safflower, olive and other plant oils in the improvement of scar and striae appearance.

Bielfeldt S, Blaak J, Staib P, Simon I, Wohlfart R, Manger C, Wilhelm KP.

Int J Cosmet Sci. 2018 Feb;40(1):81-86. doi: 10.1111/ics.12438. Epub 2017 Dec 12.

PMID:
29094366
4.

Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.

Koehler P, Hamprecht A, Bader O, Bekeredjian-Ding I, Buchheidt D, Doelken G, Elias J, Haase G, Hahn-Ast C, Karthaus M, Kekulé A, Keller P, Kiehl M, Krause SW, Krämer C, Neumann S, Rohde H, La Rosée P, Ruhnke M, Schafhausen P, Schalk E, Schulz K, Schwartz S, Silling G, Staib P, Ullmann A, Vergoulidou M, Weber T, Cornely OA, Vehreschild MJ.

Int J Antimicrob Agents. 2017 Feb;49(2):218-223. doi: 10.1016/j.ijantimicag.2016.10.019. Epub 2016 Dec 12.

PMID:
27989379
5.

MINI01.20: Interim Quality of Life (QoL) Results from ABOUND.sqm: nab-Paclitaxel/Carboplatin Induction Therapy in Squamous (SCC) NSCLC: Topic: Medical Oncology.

Thomas M, Page R, Gressot L, Daniel D, Morgensztern D, Levy B, Hussein M, Razaq M, Villaflor VM, Aix SP, Sivarajan K, Engel-Riedel W, Staib P, Ko A, Ong TJ, Trunova N, Spigel DR.

J Thorac Oncol. 2016 Nov;11(11S):S269. doi: 10.1016/j.jtho.2016.09.035. Epub 2016 Oct 28. No abstract available.

6.

Candida species Rewired Hyphae Developmental Programs for Chlamydospore Formation.

Böttcher B, Pöllath C, Staib P, Hube B, Brunke S.

Front Microbiol. 2016 Oct 27;7:1697. eCollection 2016.

7.

A plant oil-containing pH 4 emulsion improves epidermal barrier structure and enhances ceramide levels in aged skin.

Blaak J, Dähnhardt D, Dähnhardt-Pfeiffer S, Bielfeldt S, Wilhelm KP, Wohlfart R, Staib P.

Int J Cosmet Sci. 2017 Jun;39(3):284-291. doi: 10.1111/ics.12374. Epub 2016 Nov 9.

PMID:
27731889
8.

The transcriptional regulators SteA and StuA contribute to keratin degradation and sexual reproduction of the dermatophyte Arthroderma benhamiae.

Kröber A, Etzrodt S, Bach M, Monod M, Kniemeyer O, Staib P, Brakhage AA.

Curr Genet. 2017 Feb;63(1):103-116. doi: 10.1007/s00294-016-0608-0. Epub 2016 May 11.

PMID:
27170358
9.

Development and validation of the Patient Benefit Index for the dermatocosmetic treatment of aged skin.

Lohrberg D, Blaak J, Liebsch J, Staib P, Wohlfart R, Lüttje D, Schürer NY, Augustin M, Blome C.

Arch Dermatol Res. 2016 Jul;308(5):319-24. doi: 10.1007/s00403-016-1648-5. Epub 2016 Apr 27.

PMID:
27117448
10.

Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia.

Büchner T, Krug UO, Peter Gale R, Heinecke A, Sauerland MC, Haferlach C, Schnittger S, Haferlach T, Müller-Tidow C, Stelljes M, Mesters RM, Serve HL, Braess J, Spiekermann K, Staib P, Grüneisen A, Reichle A, Balleisen L, Eimermacher H, Giagounidis A, Rasche H, Lengfelder E, Görlich D, Faldum A, Köpcke W, Hehlmann R, Wörmann BJ, Berdel WE, Hiddemann W.

Leukemia. 2016 Aug;30(8):1781-4. doi: 10.1038/leu.2016.54. Epub 2016 Mar 11. No abstract available.

PMID:
26965440
11.

HapX Mediates Iron Homeostasis in the Pathogenic Dermatophyte Arthroderma benhamiae but Is Dispensable for Virulence.

Kröber A, Scherlach K, Hortschansky P, Shelest E, Staib P, Kniemeyer O, Brakhage AA.

PLoS One. 2016 Mar 9;11(3):e0150701. doi: 10.1371/journal.pone.0150701. eCollection 2016.

12.

Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia.

Krug U, Berdel WE, Gale RP, Haferlach C, Schnittger S, Müller-Tidow C, Braess J, Spiekermann K, Staib P, Beelen D, Serve H, Schliemann C, Stelljes M, Balleisen L, Maschmeyer G, Grüneisen A, Eimermacher H, Giagounidis A, Rasche H, Hehlmann R, Lengfelder E, Thiel E, Reichle A, Aul C, Ludwig WD, Kern W, Haferlach T, Köpcke W, Görlich D, Sauerland MC, Heinecke A, Wörmann BJ, Hiddemann W, Büchner T.

Leukemia. 2016 Jun;30(6):1230-6. doi: 10.1038/leu.2016.25. Epub 2016 Feb 9.

PMID:
26859081
13.

Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia.

Alpermann T, Schnittger S, Eder C, Dicker F, Meggendorfer M, Kern W, Schmid C, Aul C, Staib P, Wendtner CM, Schmitz N, Haferlach C, Haferlach T.

Haematologica. 2016 Feb;101(2):e55-8. doi: 10.3324/haematol.2015.133819. Epub 2015 Oct 15. No abstract available.

14.

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment.

Gratwohl A, Pfirrmann M, Zander A, Kröger N, Beelen D, Novotny J, Nerl C, Scheid C, Spiekermann K, Mayer J, Sayer HG, Falge C, Bunjes D, Döhner H, Ganser A, Schmidt-Wolf I, Schwerdtfeger R, Baurmann H, Kuse R, Schmitz N, Wehmeier A, Fischer JT, Ho AD, Wilhelm M, Goebeler ME, Lindemann HW, Bormann M, Hertenstein B, Schlimok G, Baerlocher GM, Aul C, Pfreundschuh M, Fabian M, Staib P, Edinger M, Schatz M, Fauser A, Arnold R, Kindler T, Wulf G, Rosselet A, Hellmann A, Schäfer E, Prümmer O, Schenk M, Hasford J, Heimpel H, Hossfeld DK, Kolb HJ, Büsche G, Haferlach C, Schnittger S, Müller MC, Reiter A, Berger U, Saußele S, Hochhaus A, Hehlmann R; SAKK; German CML Study Group.

Leukemia. 2016 Mar;30(3):562-9. doi: 10.1038/leu.2015.281. Epub 2015 Oct 14.

15.

Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML.

Fabarius A, Kalmanti L, Dietz CT, Lauseker M, Rinaldetti S, Haferlach C, Göhring G, Schlegelberger B, Jotterand M, Hanfstein B, Seifarth W, Hänel M, Köhne CH, Lindemann HW, Berdel WE, Staib P, Müller MC, Proetel U, Balleisen L, Goebeler ME, Dengler J, Falge C, Kanz L, Burchert A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Spiekermann K, Brümmendorf TH, Edinger M, Hofmann WK, Pfirrmann M, Hasford J, Krause S, Hochhaus A, Saußele S, Hehlmann R; SAKK and the German CML Study Group.

Ann Hematol. 2015 Dec;94(12):2015-24. doi: 10.1007/s00277-015-2494-9. Epub 2015 Sep 18.

PMID:
26385387
16.

Secreted aspartic protease 2 of Candida albicans inactivates factor H and the macrophage factor H-receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18).

Svoboda E, Schneider AE, Sándor N, Lermann U, Staib P, Kremlitzka M, Bajtay Z, Barz D, Erdei A, Józsi M.

Immunol Lett. 2015 Nov;168(1):13-21. doi: 10.1016/j.imlet.2015.08.009. Epub 2015 Aug 22.

PMID:
26306739
17.

A Long-Term Study to Evaluate Acidic Skin Care Treatment in Nursing Home Residents: Impact on Epidermal Barrier Function and Microflora in Aged Skin.

Blaak J, Kaup O, Hoppe W, Baron-Ruppert G, Langheim H, Staib P, Wohlfart R, Lüttje D, Schürer N.

Skin Pharmacol Physiol. 2015 Aug 1;28(5):269-279. [Epub ahead of print]

PMID:
26277854
18.

Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV.

Saussele S, Krauss MP, Hehlmann R, Lauseker M, Proetel U, Kalmanti L, Hanfstein B, Fabarius A, Kraemer D, Berdel WE, Bentz M, Staib P, de Wit M, Wernli M, Zettl F, Hebart HF, Hahn M, Heymanns J, Schmidt-Wolf I, Schmitz N, Eckart MJ, Gassmann W, Bartholomäus A, Pezzutto A, Leibundgut EO, Heim D, Krause SW, Burchert A, Hofmann WK, Hasford J, Hochhaus A, Pfirrmann M, Müller MC; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung and the German CML Study Group.

Blood. 2015 Jul 2;126(1):42-9. doi: 10.1182/blood-2015-01-617993. Epub 2015 Apr 27.

19.

Flippase (FLP) recombinase-mediated marker recycling in the dermatophyte Arthroderma vanbreuseghemii.

Yamada Y, Maeda M, Alshahni MM, Monod M, Staib P, Yamada T.

Microbiology. 2014 Oct;160(Pt 10):2122-35. doi: 10.1099/mic.0.076562-0. Epub 2014 Jul 4.

PMID:
24996827
20.

Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG.

Fiegl M, Unterhalt M, Kern W, Braess J, Spiekermann K, Staib P, Grüneisen A, Wörmann B, Schöndube D, Serve H, Reichle A, Hentrich M, Schiel X, Sauerland C, Heinecke A, Rieger C, Beelen D, Berdel WE, Büchner T, Hiddemann W; German AML Cooperative Group (AMLCG).

Leukemia. 2014 May;28(5):1001-7. doi: 10.1038/leu.2013.297. Epub 2013 Oct 22.

PMID:
24150216
22.

Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab.

Fink AM, Böttcher S, Ritgen M, Fischer K, Pflug N, Eichhorst B, Wendtner CM, Winkler D, Bühler A, Zenz T, Staib P, Mayer J, Hensel M, Hopfinger G, Wenger M, Fingerle-Rowson G, Döhner H, Kneba M, Stilgenbauer S, Busch R, Hallek M.

Leukemia. 2013 Sep;27(9):1949-52. doi: 10.1038/leu.2013.190. Epub 2013 Jun 21. No abstract available.

23.

The AutoDiSC: development and validation of a novel chemotherapy sensitivity and resistance assay.

Schinköthe T, Thiruchittampalam D, Schmidt A, Bomholt N, Staib P.

Anticancer Res. 2013 Jun;33(6):2491-8.

PMID:
23749900
24.

Global transcriptome sequencing identifies chlamydospore specific markers in Candida albicans and Candida dubliniensis.

Palige K, Linde J, Martin R, Böttcher B, Citiulo F, Sullivan DJ, Weber J, Staib C, Rupp S, Hube B, Morschhäuser J, Staib P.

PLoS One. 2013 Apr 15;8(4):e61940. doi: 10.1371/journal.pone.0061940. Print 2013.

25.

Candida albicans secreted aspartic proteases 4-6 induce apoptosis of epithelial cells by a novel Trojan horse mechanism.

Wu H, Downs D, Ghosh K, Ghosh AK, Staib P, Monod M, Tang J.

FASEB J. 2013 Jun;27(6):2132-44. doi: 10.1096/fj.12-214353. Epub 2013 Feb 19.

PMID:
23430844
26.

Factors supporting cysteine tolerance and sulfite production in Candida albicans.

Hennicke F, Grumbt M, Lermann U, Ueberschaar N, Palige K, Böttcher B, Jacobsen ID, Staib C, Morschhäuser J, Monod M, Hube B, Hertweck C, Staib P.

Eukaryot Cell. 2013 Apr;12(4):604-13. doi: 10.1128/EC.00336-12. Epub 2013 Feb 15.

27.

Keratin degradation by dermatophytes relies on cysteine dioxygenase and a sulfite efflux pump.

Grumbt M, Monod M, Yamada T, Hertweck C, Kunert J, Staib P.

J Invest Dermatol. 2013 Jun;133(6):1550-5. doi: 10.1038/jid.2013.41. Epub 2013 Jan 25.

28.

The dermatophyte species Arthroderma benhamiae: intraspecies variability and mating behaviour.

Symoens F, Jousson O, Packeu A, Fratti M, Staib P, Mignon B, Monod M.

J Med Microbiol. 2013 Mar;62(Pt 3):377-85. doi: 10.1099/jmm.0.053223-0. Epub 2012 Nov 22.

PMID:
23180475
29.

Differentiation of Candida dubliniensis from Candida albicans by means of MALDI-TOF mass spectrometry.

Hof H, Eigner U, Maier T, Staib P.

Clin Lab. 2012;58(9-10):927-31.

PMID:
23163108
30.

Clinical safety and pharmacological profile of the HLA-DR antibody 1D09C3 in patients with B cell chronic lymphocytic leukemia and lymphoma: results from a phase I study.

Schweighofer CD, Tuchscherer A, Sperka S, Meyer T, Rattel B, Stein S, Ismail S, Elter T, Staib P, Reiser M, Hallek M.

Cancer Immunol Immunother. 2012 Dec;61(12):2367-73. doi: 10.1007/s00262-012-1362-x. Epub 2012 Oct 23.

PMID:
23090290
31.

ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome.

Schnittger S, Eder C, Jeromin S, Alpermann T, Fasan A, Grossmann V, Kohlmann A, Illig T, Klopp N, Wichmann HE, Kreuzer KA, Schmid C, Staib P, Peceny R, Schmitz N, Kern W, Haferlach C, Haferlach T.

Leukemia. 2013 Jan;27(1):82-91. doi: 10.1038/leu.2012.262. Epub 2012 Sep 11.

PMID:
23018865
32.

A novel hierarchical prognostic model of AML solely based on molecular mutations.

Grossmann V, Schnittger S, Kohlmann A, Eder C, Roller A, Dicker F, Schmid C, Wendtner CM, Staib P, Serve H, Kreuzer KA, Kern W, Haferlach T, Haferlach C.

Blood. 2012 Oct 11;120(15):2963-72. doi: 10.1182/blood-2012-03-419622. Epub 2012 Aug 20.

33.

Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group.

Fischer K, Cramer P, Busch R, Böttcher S, Bahlo J, Schubert J, Pflüger KH, Schott S, Goede V, Isfort S, von Tresckow J, Fink AM, Bühler A, Winkler D, Kreuzer KA, Staib P, Ritgen M, Kneba M, Döhner H, Eichhorst BF, Hallek M, Stilgenbauer S, Wendtner CM.

J Clin Oncol. 2012 Sep 10;30(26):3209-16. doi: 10.1200/JCO.2011.39.2688. Epub 2012 Aug 6.

PMID:
22869884
34.

Differential interaction of the two related fungal species Candida albicans and Candida dubliniensis with human neutrophils.

Svobodová E, Staib P, Losse J, Hennicke F, Barz D, Józsi M.

J Immunol. 2012 Sep 1;189(5):2502-11. doi: 10.4049/jimmunol.1200185. Epub 2012 Jul 30.

35.

[Percutaneous coronary intervention in a patient with acute myeloid leukemia].

Staib P, Forsch S, Niedeggen A, Janssens U.

Dtsch Med Wochenschr. 2012 May;137(21):1092-5. doi: 10.1055/s-0032-1305014. Epub 2012 May 15. German.

PMID:
22588653
36.

Fludarabine and cyclophosphamide in combination with alemtuzumab in patients with primary high-risk, relapsed or refractory chronic lymphocytic leukemia.

Elter T, James R, Busch R, Winkler D, Ritgen M, Böttcher S, Kahl C, Gassmann W, Stauch M, Hasan I, Staib P, Fischer K, Fink AM, Bahlo J, Bühler A, Döhner H, Wendtner CM, Stilgenbauer S, Engert A, Hallek M.

Leukemia. 2012 Dec;26(12):2549-52. doi: 10.1038/leu.2012.129. Epub 2012 May 15. No abstract available.

PMID:
22584787
37.

Identification of novel secreted proteases during extracellular proteolysis by dermatophytes at acidic pH.

Sriranganadane D, Waridel P, Salamin K, Feuermann M, Mignon B, Staib P, Neuhaus JM, Quadroni M, Monod M.

Proteomics. 2011 Nov;11(22):4422-33. doi: 10.1002/pmic.201100234. Epub 2011 Oct 17.

PMID:
21919205
38.

Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patients.

Vehreschild MJ, Meissner AM, Cornely OA, Maschmeyer G, Neumann S, von Lilienfeld-Toal M, Karthaus M, Wattad M, Staib P, Hellmich M, Christ H, Vehreschild JJ.

Haematologica. 2011 Dec;96(12):1855-60. doi: 10.3324/haematol.2011.049627. Epub 2011 Aug 22.

39.

Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group.

Fischer K, Cramer P, Busch R, Stilgenbauer S, Bahlo J, Schweighofer CD, Böttcher S, Staib P, Kiehl M, Eckart MJ, Kranz G, Goede V, Elter T, Bühler A, Winkler D, Kneba M, Döhner H, Eichhorst BF, Hallek M, Wendtner CM.

J Clin Oncol. 2011 Sep 10;29(26):3559-66. doi: 10.1200/JCO.2010.33.8061. Epub 2011 Aug 15.

PMID:
21844497
40.

Targeted gene deletion and in vivo analysis of putative virulence gene function in the pathogenic dermatophyte Arthroderma benhamiae.

Grumbt M, Defaweux V, Mignon B, Monod M, Burmester A, Wöstemeyer J, Staib P.

Eukaryot Cell. 2011 Jun;10(6):842-53. doi: 10.1128/EC.00273-10. Epub 2011 Apr 8.

41.

Genetic advances in dermatophytes.

Grumbt M, Monod M, Staib P.

FEMS Microbiol Lett. 2011 Jul;320(2):79-86. doi: 10.1111/j.1574-6968.2011.02276.x. Epub 2011 May 9.

42.

Seminal plasma protects human spermatozoa and pathogenic yeasts from capture by dendritic cells.

Rennemeier C, Schwab M, Lermann U, Albert C, Kämmerer U, Frambach T, Morschhäuser J, Dietl J, Staib P.

Hum Reprod. 2011 May;26(5):987-99. doi: 10.1093/humrep/der038. Epub 2011 Feb 23.

PMID:
21345915
43.

Comparative and functional genomics provide insights into the pathogenicity of dermatophytic fungi.

Burmester A, Shelest E, Glöckner G, Heddergott C, Schindler S, Staib P, Heidel A, Felder M, Petzold A, Szafranski K, Feuermann M, Pedruzzi I, Priebe S, Groth M, Winkler R, Li W, Kniemeyer O, Schroeckh V, Hertweck C, Hube B, White TC, Platzer M, Guthke R, Heitman J, Wöstemeyer J, Zipfel PF, Monod M, Brakhage AA.

Genome Biol. 2011;12(1):R7. doi: 10.1186/gb-2011-12-1-r7. Epub 2011 Jan 19.

44.

New cis-configured aziridine-2-carboxylates as aspartic acid protease inhibitors.

Büchold C, Hemberger Y, Heindl C, Welker A, Degel B, Pfeuffer T, Staib P, Schneider S, Rosenthal PJ, Gut J, Morschhäuser J, Bringmann G, Schirmeister T.

ChemMedChem. 2011 Jan 3;6(1):141-52. doi: 10.1002/cmdc.201000370.

PMID:
21082722
45.

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.

Hallek M, Fischer K, Fingerle-Rowson G, Fink AM, Busch R, Mayer J, Hensel M, Hopfinger G, Hess G, von Grünhagen U, Bergmann M, Catalano J, Zinzani PL, Caligaris-Cappio F, Seymour JF, Berrebi A, Jäger U, Cazin B, Trneny M, Westermann A, Wendtner CM, Eichhorst BF, Staib P, Bühler A, Winkler D, Zenz T, Böttcher S, Ritgen M, Mendila M, Kneba M, Döhner H, Stilgenbauer S; International Group of Investigators; German Chronic Lymphocytic Leukaemia Study Group.

Lancet. 2010 Oct 2;376(9747):1164-74. doi: 10.1016/S0140-6736(10)61381-5.

PMID:
20888994
46.

Molecular analysis and mating behaviour of the Trichophyton mentagrophytes species complex.

Symoens F, Jousson O, Planard C, Fratti M, Staib P, Mignon B, Monod M.

Int J Med Microbiol. 2011 Mar;301(3):260-6. doi: 10.1016/j.ijmm.2010.06.001. Epub 2010 Aug 12.

PMID:
20708436
47.

Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo.

Gandhirajan RK, Staib PA, Minke K, Gehrke I, Plickert G, Schlösser A, Schmitt EK, Hallek M, Kreuzer KA.

Neoplasia. 2010 Apr;12(4):326-35.

48.

Differential gene expression in the pathogenic dermatophyte Arthroderma benhamiae in vitro versus during infection.

Staib P, Zaugg C, Mignon B, Weber J, Grumbt M, Pradervand S, Harshman K, Monod M.

Microbiology. 2010 Mar;156(Pt 3):884-95. doi: 10.1099/mic.0.033464-0. Epub 2009 Nov 26.

PMID:
19942661
49.

High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG.

Lengfelder E, Haferlach C, Saussele S, Haferlach T, Schultheis B, Schnittger S, Ludwig WD, Staib P, Aul C, Grüneisen A, Kern W, Reichle A, Serve H, Berdel WE, Braess J, Spiekermann K, Wörmann B, Sauerland MC, Heinecke A, Hiddemann W, Hehlmann R, Büchner T; German AML Cooperative Group.

Leukemia. 2009 Dec;23(12):2248-58. doi: 10.1038/leu.2009.183. Epub 2009 Sep 10.

PMID:
19741727
50.

Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapse.

Giles F, Vey N, DeAngelo D, Seiter K, Stock W, Stuart R, Boskovic D, Pigneux A, Tallman M, Brandwein J, Kell J, Robak T, Staib P, Thomas X, Cahill A, Albitar M, O'Brien S.

Blood. 2009 Nov 5;114(19):4027-33. doi: 10.1182/blood-2009-06-229351. Epub 2009 Aug 26.

Supplemental Content

Support Center